Jennifer Cauzzo

Ms. Jennifer Cauzzo

UiT The Arctic University of Norway
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MASSIMILIANO PIO DI CAGNOMASSIMILIANO PIO DI CAGNO
MASSIMILIANO PIO DI CAGNO
FCFabrizio Clarelli
Fabrizio Clarelli
JVJon Våbenø
Jon Våbenø
CLChristina Lesley
Christina Lesley
SRSokar Darsim Rahman
Sokar Darsim Rahman
PSPaul C Stein
Paul C Stein

Verified
Journal Article
Open access
PDF file
Jennifer CauzzoJennifer Cauzzo
Jennifer Cauzzo
Mona NystadMona Nystad
Mona Nystad
Ann HolsæterAnn Holsæter
Ann Holsæter
Purusotam BasnetPurusotam Basnet
Purusotam Basnet
Natasa Skalko-BasnetNatasa Skalko-Basnet
Natasa Skalko-Basnet
The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate through fluorescence-based assays, namely flow cytometry and imaging. These methods are often used to follow the nanocarrier internalization and targeting; however, the validity of the obtained results strictly depends on how much the nanosystem’s fate can be inferred from the fate of fluorescent dyes. To evaluate the parameters that affect the physicochemical and biological stability of the labeled nanosystems, we studied the versatility of two lipid dyes, TopFluor®-PC and Cy5-DSPE, in conventional liposomes utilizing well-defined in vitro assays. Our results suggest that the dye can affect the major characteristics of the system, such as vesicle size and zeta-potential. However, a nanocarrier can also affect the dye properties. Medium, temperature, time, fluorophore localization and its concentration, as well as their interplay, affect the outcome of tracing experiments. Therefore, an in-depth characterization of the labeled nanosystem should be fundamental to understand the conditions that validate the results within the screening process in optimization of nanocarrier.

21 April 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Jennifer CauzzoJennifer Cauzzo
Jennifer Cauzzo
NJNikhil Jayakumar
Nikhil Jayakumar
BABalpreet Singh Ahluwalia
Balpreet Singh Ahluwalia
AAAzeem Ahmad
Azeem Ahmad
Natasa Skalko-BasnetNatasa Skalko-Basnet
Natasa Skalko-Basnet
The rapid development of nanomedicine and drug delivery systems calls for new and effective characterization techniques that can accurately characterize both the properties and the behavior of nanosystems. Standard methods such as dynamic light scattering (DLS) and fluorescent-based assays present challenges in terms of system’s instability, machine sensitivity, and loss of tracking ability, among others. In this study, we explore some of the downsides of batch-mode analyses and fluorescent labeling, while introducing quantitative phase microscopy (QPM) as a label-free complimentary characterization technique. Liposomes were used as a model nanocarrier for their therapeutic relevance and structural versatility. A successful immobilization of liposomes in a non-dried setup allowed for static imaging conditions in an off-axis phase microscope. Image reconstruction was then performed with a phase-shifting algorithm providing high spatial resolution. Our results show the potential of QPM to localize subdiffraction-limited liposomes, estimate their size, and track their integrity over time. Moreover, QPM full-field-of-view images enable the estimation of a single-particle-based size distribution, providing an alternative to the batch mode approach. QPM thus overcomes some of the drawbacks of the conventional methods, serving as a relevant complimentary technique in the characterization of nanosystems.